Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Green Valley Obtains IND Approval from U.S. FDA for Sodium Oligomannate's International, Phase III Clinical Study

prnasiaApril 27, 2020

Tag: Green Valley , Sodium Oligomannate , Phase III Clinical Study

PharmaSources Customer Service